627: Scientist Reveals a Newly Discovered Cause of Insulin Resistance (Not Carb Related) | Dr. Stephanie Venn-Watson

Dr. Stephanie Venn-Watson is the CEO of Seraphina Therapeutics which has been recognized for its extensive research and education on pentadecanoic acid (C15:0). Show sponsor: Show notes: